209 related articles for article (PubMed ID: 5041307)
1. [Diagnosis and identification of idiopathic hyperlipemia. A new test. Comparison of circulating lipid concentrations after 8 and 12 hours of fasting].
de Gennes JL; Turpin G; Truffert J
Nouv Presse Med; 1972 Jun; 1(24):1627-32. PubMed ID: 5041307
[No Abstract] [Full Text] [Related]
2. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)].
Loeper J; Rouffy J; Loeper J
Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789
[No Abstract] [Full Text] [Related]
3. Double screening test at 8th and 12th hour of overnight fasting for a better classification of idiopathic hyperlipidemias. Large scale study of 505 tests.
De Gennes JL; Dairou F; Truffert J
Diabete Metab; 1981 Sep; 7(3):161-7. PubMed ID: 7319115
[TBL] [Abstract][Full Text] [Related]
4. [Skin and lipid metabolism disorders].
Luger A
Z Haut Geschlechtskr; 1971 Oct; 46(19):642-72. PubMed ID: 5137247
[No Abstract] [Full Text] [Related]
5. [Study of mixed hyperlipemia with a distinct excess of beta and pre-beta lipoproteins (78 cases)].
Loeper J; Rouffy J; Loeper J
Presse Med (1893); 1971 Apr; 79(18):797-800. PubMed ID: 5574509
[No Abstract] [Full Text] [Related]
6. [Plasma lipids in health control. Diagnosis of asymptomatic hyperlipemia].
Carlson LA; Ekelund LG; Eklund B; Olsson AG
Lakartidningen; 1972 Oct; 69(41):4655-8. PubMed ID: 5072454
[No Abstract] [Full Text] [Related]
7. [Theoretical and practical importance of the comparison of chemical and electrophoretic lipid formula at the 8th and 12th hour of fasting in idiopathic hyperlipidemias].
de Gennes JL; Turpin G; Truffert J
C R Acad Hebd Seances Acad Sci D; 1971 Dec; 273(23):2312-5. PubMed ID: 5003398
[No Abstract] [Full Text] [Related]
8. [Mixed hyperlipemia (apropos of 231 cases)].
Loeper J; Rouffy J; Mouret A; Le Douaron J
Ann Med Interne (Paris); 1971 May; 122(5):551-7. PubMed ID: 5563708
[No Abstract] [Full Text] [Related]
9. Comparison of clinical findings in patients with hyperglyceridaemia and familial hypercholesterolaemia.
Miettinen TA; Aro A
Ann Clin Res; 1973 Feb; 5(1):1-6. PubMed ID: 4695649
[No Abstract] [Full Text] [Related]
10. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness.
Mabuchi H; Ito S; Haba T; Ueda K; Ueda R
Atherosclerosis; 1977 Sep; 28(1):61-8. PubMed ID: 911369
[No Abstract] [Full Text] [Related]
11. [Serum cholesterol in endogenous hyperlipidemia (type IV)].
Wille LE
Tidsskr Nor Laegeforen; 1972 Nov; 92(31):2089-92. PubMed ID: 4656549
[No Abstract] [Full Text] [Related]
12. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
[No Abstract] [Full Text] [Related]
13. [Systematic study of a median tolerance to a high-fat test diet in hyperlipemia or hyperglyceridemia].
de Gennes JL; Truffert J; Salmon D; de Tregomain B; Bouchon JP
Ann Med Interne (Paris); 1969 Dec; 120(12):787-802. PubMed ID: 5377660
[No Abstract] [Full Text] [Related]
14. [Differentiation characteristics for the identification of patients with familial hypercholesteremia - studies on skin fibroblasts].
Wieczorek A; Zöllner N
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():381-2. PubMed ID: 206053
[No Abstract] [Full Text] [Related]
15. [Alcohol-sensitive hyperlipemia. Clinical and biological study based on 40 cases].
Drouin P; Pointel JP; Guisard D; Debry G
Ann Biol Clin (Paris); 1973; 31(2):163-5. PubMed ID: 4749235
[No Abstract] [Full Text] [Related]
16. [Atherogenic hyperproteinemia. Value of identification in children].
Loeper J; Rouffy J; Loeper J
Presse Med (1893); 1970 May; 78(27):1219-22. PubMed ID: 5421544
[No Abstract] [Full Text] [Related]
17. [Clinically relevant parameters in disturbed lipid metabolism].
Berg G; Grabner W
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:7-16. PubMed ID: 4505210
[No Abstract] [Full Text] [Related]
18. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. I. Patient data in the light of anamestic and subjective symptoms].
Olejak B; Szmatłoch E; Gregorczyk J; Cwajda H; Pieczul-Mróz J; Ansilewski K; Kornacewicz-Jach Z; Brzeźniak R
Przegl Lek; 1983; 40(9):671-6. PubMed ID: 6665224
[No Abstract] [Full Text] [Related]
19. [Hyperlipoproteinemia type 3. Report on 5 cases].
Weber K; Braun-Falco O; Wolfram G
Hautarzt; 1973 May; 24(5):179-85. PubMed ID: 4753368
[No Abstract] [Full Text] [Related]
20. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
Roe DA
Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
